Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Repeat administration of proteins to the eye with a single intraocular injection of an adenovirus vector.

McVey D, Hamilton MM, Hsu C, King CR, Brough DE, Wei LL.

Mol Ther. 2008 Aug;16(8):1444-9. doi: 10.1038/mt.2008.124. Epub 2008 Jun 10.

PMID:
18545220
2.

Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.

Hamilton MM, Byrnes GA, Gall JG, Brough DE, King CR, Wei LL.

Mol Vis. 2008;14:2535-46. Epub 2008 Dec 30.

3.

Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.

Gehlbach P, Demetriades AM, Yamamoto S, Deering T, Duh EJ, Yang HS, Cingolani C, Lai H, Wei L, Campochiaro PA.

Gene Ther. 2003 Apr;10(8):637-46.

PMID:
12692592
4.

Persistent expression of PEDF in the eye using high-capacity adenovectors.

Chen P, Hamilton M, Thomas CA, Kroeger K, Carrion M, Macgill RS, Gehlbach P, Brough DE, Wei LL, King CR, Bruder JT.

Mol Ther. 2008 Dec;16(12):1986-94. doi: 10.1038/mt.2008.211. Epub 2008 Sep 30.

PMID:
18827806
5.

AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.

Mori K, Gehlbach P, Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1994-2000.

PMID:
12037010
6.

Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.

Mol Vis. 2008 Sep 24;14:1760-9.

7.

Adenovector pigment epithelium-derived factor (AdPEDF) delivery for wet age-related macular degeneration.

Wei L.

Retina. 2005 Dec;25(8 Suppl):S48-S49. Review. No abstract available.

PMID:
16374334
8.

Gene therapy for ocular neovascularization: a cure in sight.

Reich SJ, Bennett J.

Curr Opin Genet Dev. 2003 Jun;13(3):317-22.

PMID:
12787796
9.

Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins.

Murakami Y, Ikeda Y, Yonemitsu Y, Miyazaki M, Inoue M, Hasegawa M, Sueishi K, Ishibashi T.

Hum Gene Ther. 2010 Feb;21(2):199-209. doi: 10.1089/hum.2009.102.

PMID:
19778186
10.
11.

Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma.

Yang LP, Cheng P, Peng XC, Shi HS, He WH, Cui FY, Luo ST, Wei YQ, Yang L.

J Exp Clin Cancer Res. 2009 Jun 5;28:75. doi: 10.1186/1756-9966-28-75.

12.

Repeated administration of adenovector in the eye results in efficient gene delivery.

Hamilton MM, Brough DE, McVey D, Bruder JT, King CR, Wei LL.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):299-305.

PMID:
16384977
13.

Promoters influence the kinetics of transgene expression following adenovector gene delivery.

Chen P, Tian J, Kovesdi I, Bruder JT.

J Gene Med. 2008 Feb;10(2):123-31.

PMID:
18064718
14.

A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions.

Hou HY, Liang HL, Wang YS, Zhang ZX, Wang BR, Shi YY, Dong X, Cai Y.

Mol Ther. 2010 Oct;18(10):1837-45. doi: 10.1038/mt.2010.144. Epub 2010 Jul 20.

15.

Sustained expression after nonviral ocular gene transfer using mammalian promoters.

Kachi S, Esumi N, Zack DJ, Campochiaro PA.

Gene Ther. 2006 May;13(9):798-804.

PMID:
16467860
16.

Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye.

Saishin Y, Silva RL, Saishin Y, Kachi S, Aslam S, Gong YY, Lai H, Carrion M, Harris B, Hamilton M, Wei L, Campochiaro PA.

Hum Gene Ther. 2005 Apr;16(4):473-8.

PMID:
15871678
17.

Gene therapy for ocular angiogenesis.

Bainbridge JW, Mistry AR, Thrasher AJ, Ali RR.

Clin Sci (Lond). 2003 Jun;104(6):561-75. Review.

PMID:
12570869
18.

TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection.

Yao X, Yoshioka Y, Eto Y, Morishige T, Okada Y, Mizuguchi H, Mukai Y, Okada N, Nakagawa S.

Biochem Biophys Res Commun. 2007 Oct 19;362(2):419-24. Epub 2007 Aug 9.

PMID:
17707336
19.

[Current and future trends in gene therapy for diabetic retinopathies].

Mori K.

Nihon Rinsho. 2005 Jun;63 Suppl 6:250-5. Review. Japanese. No abstract available.

PMID:
15999715
20.

Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus.

Park CY, Chuck RS, Cano M, Yew M, Nguyen V, Parker J, Mori K, Gehlbach PL.

Invest Ophthalmol Vis Sci. 2008 Jan;49(1):399-406. doi: 10.1167/iovs.07-0619.

PMID:
18172118
Items per page

Supplemental Content

Write to the Help Desk